Glucocorticoid and its effect on cardiac glucose utilization
Glycogen is an immediate source of glucose for cardiac tissue to maintain its metabolic homeostasis. However, its excess brings about cardiac structural and physiological impairments. Previously, we have demonstrated that in hearts from dexamethasone (DEX) treated animals, glycogen accumulation was...
Main Author: | |
---|---|
Format: | Others |
Language: | English |
Published: |
University of British Columbia
2009
|
Subjects: | |
Online Access: | http://hdl.handle.net/2429/5038 |
id |
ndltd-UBC-oai-circle.library.ubc.ca-2429-5038 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-UBC-oai-circle.library.ubc.ca-2429-50382018-01-05T17:23:16Z Glucocorticoid and its effect on cardiac glucose utilization Puthanveetil, Prasanth Nair AMPK Glycogen Glycogen is an immediate source of glucose for cardiac tissue to maintain its metabolic homeostasis. However, its excess brings about cardiac structural and physiological impairments. Previously, we have demonstrated that in hearts from dexamethasone (DEX) treated animals, glycogen accumulation was enhanced. We examined the influence of DEX on glucose entry and glycogen synthase as a means of regulating the accumulation of this stored polysaccharide. Following DEX, cardiac tissue had limited contribution towards the development of whole body insulin resistance. Measurement of GLUT4 at the plasma membrane revealed an excess presence of this transporter protein at this location. Interestingly, this was accompanied by an increase in GLUT4 in the intracellular membrane fraction, an effect that was well correlated to an increased GLUT4 mR.NA. Both total and phosphorylated AMPK increased following DEX. Immunoprecipitation of AS 160 followed by Western blotting demonstrated no change in Akt phosphorylation at Ser473 and Thr308 in DEX treated hearts. However, there was a significant increase in AMPK phosphorylation at Thr172, which correlated well with AS 160 phosphorylation. In DEX hearts, there was a considerable reduction in the phosphorylation of glycogen synthase, whereas GSK-3-β phosphorylation was augmented. Our data suggest that AMPK mediated glucose entry, combined with activation of glycogen synthase and reduction in glucose oxidation (Qi, D., et al. Diabetes 53:1790, 2004), act together to promote glycogen storage. Our data suggest that in the presence of intact insulin signaling, AMPK mediated glucose entry, combined with activation of glycogen synthase and the previously reported reduction in glucose oxidation, act together to promote glycogen storage. Should these effects persist chronically, they may explain the increased morbidity and mortality observed with long term excesses in endogenous or exogenous glucocorticoids. Pharmaceutical Sciences, Faculty of Graduate 2009-02-25T18:34:29Z 2009-02-25T18:34:29Z 2008 2008-11 Text Thesis/Dissertation http://hdl.handle.net/2429/5038 eng Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ 1393576 bytes application/pdf University of British Columbia |
collection |
NDLTD |
language |
English |
format |
Others
|
sources |
NDLTD |
topic |
AMPK Glycogen |
spellingShingle |
AMPK Glycogen Puthanveetil, Prasanth Nair Glucocorticoid and its effect on cardiac glucose utilization |
description |
Glycogen is an immediate source of glucose for cardiac tissue to maintain its metabolic
homeostasis. However, its excess brings about cardiac structural and physiological
impairments. Previously, we have demonstrated that in hearts from dexamethasone
(DEX) treated animals, glycogen accumulation was enhanced. We examined the
influence of DEX on glucose entry and glycogen synthase as a means of regulating the
accumulation of this stored polysaccharide. Following DEX, cardiac tissue had limited
contribution towards the development of whole body insulin resistance. Measurement of
GLUT4 at the plasma membrane revealed an excess presence of this transporter protein
at this location. Interestingly, this was accompanied by an increase in GLUT4 in the
intracellular membrane fraction, an effect that was well correlated to an increased
GLUT4 mR.NA. Both total and phosphorylated AMPK increased following DEX.
Immunoprecipitation of AS 160 followed by Western blotting demonstrated no change in
Akt phosphorylation at Ser473 and Thr308 in DEX treated hearts. However, there was a
significant increase in AMPK phosphorylation at Thr172, which correlated well with
AS 160 phosphorylation. In DEX hearts, there was a considerable reduction in the
phosphorylation of glycogen synthase, whereas GSK-3-β phosphorylation was
augmented. Our data suggest that AMPK mediated glucose entry, combined with
activation of glycogen synthase and reduction in glucose oxidation (Qi, D., et al. Diabetes
53:1790, 2004), act together to promote glycogen storage. Our data suggest that in the
presence of intact insulin signaling, AMPK mediated glucose entry, combined with
activation of glycogen synthase and the previously reported reduction in glucose
oxidation, act together to promote glycogen storage. Should these effects persist chronically, they may explain the increased morbidity and mortality observed with long
term excesses in endogenous or exogenous glucocorticoids. === Pharmaceutical Sciences, Faculty of === Graduate |
author |
Puthanveetil, Prasanth Nair |
author_facet |
Puthanveetil, Prasanth Nair |
author_sort |
Puthanveetil, Prasanth Nair |
title |
Glucocorticoid and its effect on cardiac glucose utilization |
title_short |
Glucocorticoid and its effect on cardiac glucose utilization |
title_full |
Glucocorticoid and its effect on cardiac glucose utilization |
title_fullStr |
Glucocorticoid and its effect on cardiac glucose utilization |
title_full_unstemmed |
Glucocorticoid and its effect on cardiac glucose utilization |
title_sort |
glucocorticoid and its effect on cardiac glucose utilization |
publisher |
University of British Columbia |
publishDate |
2009 |
url |
http://hdl.handle.net/2429/5038 |
work_keys_str_mv |
AT puthanveetilprasanthnair glucocorticoidanditseffectoncardiacglucoseutilization |
_version_ |
1718581916550037504 |